Accelerate to discover
Related topics
Identify the quality of any protein in 3 minutes using microliters of sample with Tycho
Jul 19, 2019
Tycho tells you so much about the quality of your protein. It tells you about presence, purity, concentration,...
Expanding patient tumor samples has never been so easy - Discover AVATAR
Jul 10, 2019
The AVATAR Cell Control System lets you fine-tune oxygen and pressure to cater culture conditions to your cell type of...
Jul 4, 2019
Cutting edgce cardiovascular research demands cutting edge technology. 4D imaging brings together dynamic motion and 3D...
CQ1 confocal quantitative image cytometer: fighting colon cancer with killer cells
Jul 2, 2019
Genetically modified immune cells can successfully destroy colon cancer cells. This has been demonstrated for the first...
Assessment of angiotensin II-induced mouse models of abdominal aortic aneurysm
Jun 28, 2019
Are you working with high ultrasound imaging and are you interesting in progression/ regression of abdominal aortic...
Bionano introduce new SP blood and cell culture DNA isolation kit
Jun 26, 2019
This Bionano prep SP blood and cell culture DNA isolation kit, can provide ultra-high molecular weight (UHMW) gDNA in...
Breast cancer‐derived exosomes reflect the cell of origin phenotype
Jun 24, 2019
The qNano Gold measures particles using the Tunable Resistive Pulse Sensing (TRPS) principle. TRPS is the most powerful...
Transcutaneous implantation of valproic acid-encapsulated
Jun 21, 2019
The interest in alternative material systems and delivery methods for treatment of androgenetic alopecia has been...
Jun 30, 2017
Mycoplasma hominis is a species of bacteria able to infect and penetrate the interior of human cells. It is notoriously difficult to test for and resistant to most antibiotics. In transplant recipients, M. hominis infections can lead to pleurisy, surgical site infection and tissue inflammation in the chest. As the pathogen is typically found in the genitourinary tract, it was unknown how heart and lung transplant recipients were acquiring this specific species of bacteria.
The study by the Mayo Clinic investigated current M. hominis detection mechanisms. Current methods of testing for this pathogen were thought to be inadequate which prompted Robin Patel, M.D., Mayo Clinic, to develop a new technique which utilises the Polymerase Chain Reaction. This method is much faster than traditional culture media tests which take up to five days to complete.
Related technologies: World´s fastest qPCR thermal cycler
Get more info
Brand profile
BJS Biotechnologies manufactures The Fastest qPCR thermal cycler in the World.
More info at:
www.xxpresspcr.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
